Expression of p53 protein in benign and malignant epidermal pathologic conditions

Journal of the American Academy of Dermatology

Volumn 29, Issue 5, 1993, Pages 741-748

  Helander, Steven D ^a   Peters, Margot S ^a   Pittelkow, Mark R ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; POLYCLONAL ANTIBODY;

ARTICLE; BASAL CELL CARCINOMA; CARCINOGENESIS; CELL GROWTH; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENETIC HETEROGENEITY; HUMAN; KERATINOCYTE; KERATOACANTHOMA; MUTATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PSORIASIS; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ANTIBODIES, MONOCLONAL; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELL LINE, TRANSFORMED; CROSS REACTIONS; FROZEN SECTIONS; GENE EXPRESSION; GENES, P53; HUMAN; KERATINOCYTES; KERATOACANTHOMA; PARAFFIN EMBEDDING; PROTEIN P53; PSORIASIS; SKIN; SKIN NEOPLASMS;

EID: 0027378327     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/0190-9622(93)70240-T     Document Type: Article

References (30)

1. T antigen is bound to a host protein in SV40-transformed cells
2. The role of p53 in the normal control of cell proliferation
3. The p53 tumour suppressor gene
4. p53: Oncogene or anti-oncogene?
5. Widespread p53 overexpression in human malignant tumors: an immuno-histochemical study using methacarn-fixed, embedded tissue
6. p53 mutations in human cancers
7. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies
8. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
9. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene
10. Structural aspects of the p53 protein in relation to gene evolution
11. cdc2 in mammalian cells: implications for cell cycle control and oncogenesis
12. Levels of p53 protein increase with maturation in human hematopoietic cells
13. Participation of p53 protein in the cellular response to DNA damage
14. p53 shares an antigenic determinant with proteins of 92 and 150 kilodal-tons that may be involved in senescence of human cells
15. Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: clonal analyses, growth kinetics and cell cycle studies
16. Precise epitope mapping of the murine transformation-associated protein, p53
17. Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression
18. Analysis of p53 expression in human tumors: an antibody raised against human p53 expressed in Escherichia coli
19. Activating mutations in p53 produce a common conformational effect: a monoclonal antibody specific for the mutant form
20. Expression of p53 in premalignant and malignant squamous epithelium
21. Monoclonal antibody analysis of p53 expression in normal and transformed cells
22. Analysis of human p53 proteins and mRNA levels in normal and transformed cells
23. Radioimmunoassay of the cellular protein p53 in mouse and human cell lines
24. Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells
25. Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells
26. Nuclear localization is essential for the activity of p53 protein
27. P53 and oncogenes expression in psoriasis
28. Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene
29. Abnormal expression of wild type p53 protein in normal cells of a cancer family patient
30. p53 in pathology: Can we trust immunocytochemistry? [Editorial]